Brar Amarpali, Markell Mariana, Stefanov Dimitre G, Timpo Edem, Jindal Rahul M, Nee Robert, Sumrani Nabil, John Devon, Tedla Fasika, Salifu Moro O
Department of Medicine, SUNY Downstate School of Medicine, Brooklyn, NY, USA.
Am J Nephrol. 2017;45(2):180-186. doi: 10.1159/000455015. Epub 2017 Jan 21.
The outcomes of patients who fail their kidney transplant and return to dialysis (RTD) has not been investigated in a nationally representative sample. We hypothesized that variations in management of transplant chronic kidney disease stage 5 leading to kidney allograft failure (KAF) and RTD, such as access, nutrition, timing of dialysis, and anemia management predict long-term survival.
We used an incident cohort of patients from the United States Renal Data System who initiated hemodialysis between January 1, 2003 and December 31, 2008, after KAF. We used Cox regression analysis for statistical associations, with mortality as the primary outcome.
We identified 5,077 RTD patients and followed them for a mean of 30.9 ± 22.6 months. Adjusting for all possible confounders at the time of RTD, the adjusted hazards ratio (AHR) for death was increased with lack of arteriovenous fistula at initiation of dialysis (AHR 1.22, 95% CI 1.02-1.46, p = 0.03), albumin <3.5 g/dL (AHR 1.33, 95% CI 1.18-1.49, p = 0.0001), and being underweight (AHR 1.30, 95% CI 1.07-1.58, p = 0.006). Hemoglobin <10 g/dL (AHR 0.96, 95% CI 0.86-1.06, p = 0.46), type of insurance, and zip code-based median household income were not associated with higher mortality. Glomerular filtration rate <10 mL/min/1.73 m2 at time of dialysis initiation (AHR 0.83, 95% CI 0.75-0.93, p = 0.001) was associated with reduction in mortality.
Excess mortality risk observed in patients starting dialysis after KAF is multifactorial, including nutritional issues and vascular access. Adequate preparation of patients with failing kidney transplants prior to resuming dialysis may improve outcomes.
在全国代表性样本中,尚未对肾移植失败并恢复透析(RTD)患者的预后进行研究。我们假设,移植慢性肾脏病5期导致肾移植失败(KAF)和RTD的管理差异,如血管通路、营养、透析时机和贫血管理等,可预测长期生存情况。
我们使用了美国肾脏数据系统中2003年1月1日至2008年12月31日期间在KAF后开始血液透析的患者的发病队列。我们使用Cox回归分析统计关联,以死亡率作为主要结局。
我们确定了5077例RTD患者,并对他们进行了平均30.9±22.6个月的随访。在RTD时对所有可能的混杂因素进行调整后,透析开始时缺乏动静脉内瘘(调整后风险比[AHR]为1.22,95%置信区间为1.02-1.46,p=0.03)、白蛋白<3.5 g/dL(AHR为1.33,95%置信区间为1.18-1.49,p=0.0001)和体重过轻(AHR为1.30,95%置信区间为1.07-1.58,p=0.006)与死亡的调整后风险比增加相关。血红蛋白<10 g/dL(AHR为0.96,95%置信区间为0.86-1.06,p=0.46)、保险类型和基于邮政编码的家庭收入中位数与较高死亡率无关。透析开始时肾小球滤过率<10 mL/min/1.73 m2(AHR为0.83,95%置信区间为0.75-0.93,p=0.001)与死亡率降低相关。
KAF后开始透析的患者中观察到的额外死亡风险是多因素的, 包括营养问题和血管通路。肾移植失败患者在恢复透析前进行充分准备可能会改善预后。